Research and Development: Page 2

Oxford Nanopore to collaborate on Singapore's national sequencing initiative
By LabPulse.com staff writers
Oxford Nanopore will participate in Singapore's National Precision Medicine program, which is aimed at developing a comprehensive genetic catalog of the country's population.
August 6, 2024
Genome Sequence Barcode Social
Immunovia completes development of blood test for pancreatic cancer
By Liz Carey
What's next for company after moving testing laboratory to North Carolina.
August 5, 2024
Pancreas New Social
Leuko receives $4.5M SBIR grant for blood monitoring device
By LabPulse.com staff writers
Medtech firm Leuko has received a $4.5 million award from the U.S. National Institutes of Health National Cancer Institute to advance the development of PointCheck, its noninvasive at-home white blood cell monitoring device.
July 24, 2024
Research Money Social
Tiba Biotech awarded BARDA contract for influenza therapeutics
By LabPulse.com staff writers
Tiba Biotech has been awarded an Easy Broad Agency Announcement R&D contract through the Biomedical Advanced Research and Development Authority (BARDA) to develop therapeutics against influenza.
July 12, 2024
Influenza Virus Social
BARDA awards Moderna $176M for pandemic flu vaccine development
By LabPulse.com staff writers
The Biomedical Advanced Research and Development Authority (BARDA) has awarded Moderna approximately $176 million for the development of an mRNA-based pandemic influenza vaccine.
July 2, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles (yellow), grown in Madin-Darby Canine Kidney (MDCK) epithelial cells (blue). Microscopy by CDC; repositioned and recolored by NIAID.
Lab-on-a-chip nanogenerator device developed for monitoring blood conductivity
By Liz Carey
Self-powered millifluidic device works off triboelectrification and opens the possibility of designing implantable, self-powered diagnostic devices.
June 25, 2024
Labonachip Nanogenerator Pitt2024
Thermo Fisher's $58M research lab expansion adds 350 new jobs in Wis.
By LabPulse.com staff writers
Thermo Fisher Scientific's new PPD clinical research laboratory building in Wisconsin will create 350 new jobs for scientists, adding to a workforce of nearly 2,300 at the facility, the company announced.
June 19, 2024
Thermo Fisher Scientific Social
FDA stops BioNTech MediLink study due to 'significant risks,' adverse events
By LabPulse.com staff writers
Conducted in both the U.S. and China, the YL202 study aimed to evaluate the safety and tolerability of the ADC as a later-line treatment for some cancers.
June 18, 2024
Clinical Trial Data Network Social (1)
Roche, Ascidian to develop gene therapies for neurological diseases
By LabPulse.com staff writers
Roche has announced a research collaboration and licensing agreement with biotech firm Ascidian Therapeutics to develop gene therapies for neurological diseases.
June 19, 2024
Messenger Rna M Rna Social
ALZpath, Roche sign licensing agreement for dementia biomarker
By LabPulse.com staff writers
ALZpath has signed a licensing agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize a diagnostic blood test for Alzheimer's disease that will be offered on the Roche Elecsys platform.
June 12, 2024
Amyloid Plaque Alzheimer2 Social
Qiagen, Myriad Genetics to develop HRD test
By LabPulse.com staff writers
As part of their recently announced collaboration, Qiagen and Myriad Genetics will develop a kit-based test for analyzing homologous recombination deficiency (HRD) status.
June 5, 2024
Test Tubes Social
Genialis, PanCAN partner to validate KRAS biomarker for pancreatic cancer
By LabPulse.com staff writers
Biomarker company Genialis and the Pancreatic Cancer Action Network (PanCAN) are collaborating to further the validation of the Genialis KrasID biomarker for pancreatic cancer using PanCAN's Know Your Tumor precision medicine service.
June 3, 2024
Pancreas New Social
Previous Page
Page 2 of 41
Next Page